| Name | Title | Contact Details |
|---|---|---|
Devon Sharp |
Associate General Counsel | Profile |
Grant Riedesel |
Head of Legal, Corporate Development | Profile |
Tim Stow |
Global Head of Ethics and Compliance | Profile |
Sean Griffin |
Vice President of Regulatory Affairs | Profile |
At Jack Nathan Health, we are committed to improving access to public health care to over 1.1 million patients per-year by delivering consistent, quality care in state-of-the-art medical and dental clinics in Walmart stores across Canada. Jack Nathan Health is proud to partner with Walmart Canada to deliver quality health care services and convenience to its customers. Walmart currently operates over 390 stores and serves more than 1 million customers each day across Canada. They are the third largest employer in Canada with more than 90,000 associates and offer a full range of groceries, general merchandise and specialty services - including Medical & Dental Clinics - under one roof.
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
American College Health Association is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
N L Communications is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Addiction Recovery Care provides residential and outpatient drug and alcohol addiction treatment.